Nucleotide Metabolism Study Notes

Nucleotide Metabolism

Overview

  • This lecture covers the following topics:

    • Degradation of nucleic acids

    • Metabolic pathways for nucleotide synthesis

    • Metabolic pathways for nucleotide breakdown

Nucleosides and Nucleotides

  • Definition of Nucleosides and Nucleotides:

    • Nucleoside: Consists of a nitrogenous base + ribose.

    • Nucleotide: Consists of nitrogenous base + ribose + phosphate.

Purines vs. Pyrimidines

  • Purines: Adenine and Guanine.

  • Pyrimidines: Cytosine (DNA), Thymine (RNA), Uracil (RNA).

Nucleotide Significance

  • Nucleotides serve several critical roles:

    • Precursors for DNA and RNA synthesis.

    • Essential carriers of chemical energy (particularly ATP).

    • Components of cofactors such as NAD+, FAD, and coenzyme A.

    • Formation of activated intermediates; examples include UDP-glucose and CDP-diacylglycerol.

    • Function as second messengers (cAMP and cGMP) in cell signaling.

Pathways to Nucleotides

1. De Novo Synthesis

  • Definition: The synthesis of nucleotides from basic metabolic precursors like amino acids, ribose-5-phosphate, CO2, and one-carbon units.

  • Process: Occurs primarily in the cytosol of liver, small intestine, and thymus.

  • Purine Synthesis Details:

    • Begins with 5-phosphoribose (R-5-P).

    • PRPP (5-phosphoribosyl-1-pyrophosphate) is the key donor of R-5-P.

    • Nucleotides AMP and GMP are derived from IMP (Inosine-5'-monophosphate).

    • Involves 11 steps overall and requires specific amino acids (Aspartate, Glycine, Glutamine) and CO2.

  • Energy Requirements:

    • Many ATP molecules are utilized during the de novo synthesis pathway.

    • Regulation: The pathway is highly regulated at multiple steps to ensure balanced nucleotide levels.

2. Salvage Pathways

  • Definition: Synthesis of nucleotides by recycling free bases/nucleosides released from nucleic acid breakdown.

  • Highlights the importance of nucleotide recycling in certain tissues (e.g., brain, bone marrow).

De Novo Synthesis of Purines

Synthesis of Inosine Monophosphate (IMP)

  • The pathway includes the following key steps:

    1. Activation of Ribose-5-phosphate: The first step is the conversion by PRPP.

    2. Acquisition of purine atoms N9: This is a tightly regulated step influencing the entire pathway.

    3. Addition of C4, C5, N7: Various enzymes are involved at this stage to ensure proper synthesis.

    4. Ring Closure to form IMP: This is the penultimate step of purine synthesis before conversion to AMP or GMP.

Synthesis of AMP and GMP

  • AMP synthesis: Derived through an addition of N from aspartate; input of GTP.

  • GMP synthesis: Achieved via oxidation at C-2 followed by substitution by N from Glutamine; ATP is used as an energy source.

Regulation of Nucleotide Synthesis

  • Importance: Helps to meet the metabolic requirements of the organism without wasting energy.

    • Feedback Mechanisms: Essential in controlling the synthesis of AMP and GMP from IMP based on cellular demands.

  • Pathway intermediates are also targets for regulatory mechanisms to maintain nucleotide equilibria.

Salvage Pathway for Purines

  • Involves the recycling of hypoxanthine and guanine by two enzymes:

    • APRT (adenine phosphoribosyl transferase) for adenine.

    • HGPRT (hypoxanthine guanine phosphoribosyl transferase) for guanine or hypoxanthine.

  • Significance: Essential due to some tissues being incapable of synthesizing nucleotides through de novo pathways.

    • Clinical Note: Absence of HGPRT leads to Lesch-Nyhan syndrome, characterized by increased purine synthesis and elevated uric acid.

Purine Degradation

  • Purine metabolism leads to the formation of uric acid as the final product. Key enzymes in degradation include:

    • Nucleotidases and nucleosidases that help release ribose and phosphates.

    • Xanthine Oxidase: Converts xanthine to uric acid.

  • Uric Acid Overview:

    • Excreted at a rate of approximately 0.6 g/24 h in normal adults.

    • Uric acid levels are clinically relevant; normal serum concentrations are in the range of 3-7 mg/dl.

Gout

  • A clinical condition caused by the crystallization of uric acid within joints, leading to inflammation.

    • Predominantly affects men and can lead to comorbid conditions including kidney damage due to crystal deposition.

De Novo Synthesis of Pyrimidines

  • The process involves a shorter pathway (6 steps vs. 11 for purines):

    • Begins with the formation of the pyrimidine ring, followed by attachment to ribose-5-phosphate.

    • Key precursors include aspartate, glutamine, and bicarbonate.

    • Final Product: UMP (uridine monophosphate).

Summary Points

  • The purine synthesis pathway is highly complex and utilizes multiple amino acids and catalytic steps; pyrimidine synthesis is a simpler process.

  • Both de novo synthesis pathways are tightly regulated by feedback mechanisms to modulate enzyme activity based on the metabolic state of the cell.

  • Pathways for nucleotide catabolism produce uric acid and urea as final degradation products, with genetic deficiencies in salvage pathways leading to significant diseases.